David Zemmour
Overview
Explore the profile of David Zemmour including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
2669
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olivas A, Ngai P, Schahrer E, Olortegui K, Cursio J, Akiyama S, et al.
bioRxiv
. 2025 Feb;
PMID: 39974918
Background And Aims: Total abdominal colectomy (TAC) with a staged ileal pouch-anal anastomosis (IPAA) is a common surgical treatment for ulcerative colitis (UC). However, a significant percentage of patients experience...
2.
Borys S, Reilly S, Magill I, Zemmour D, Brossay L
Sci Immunol
. 2024 Dec;
9(102):eadl2967.
PMID: 39705335
The increasing use of anti-programmed cell death 1 (PD-1) immune checkpoint blockade has led to the emergence of immune-related adverse events (irAEs), including dysfunction of the submandibular gland (SMG). In...
3.
Sadigh S, DeAngelo D, Garcia J, Hasserjian R, Hergott C, Lane A, et al.
Mod Pathol
. 2023 Oct;
37(1):100352.
PMID: 37839675
In this study, we performed a comprehensive molecular analysis of paired skin and peripheral blood/bone marrow (BM) samples from 17 patients with cutaneous myeloid or cutaneous histiocytic-dendritic neoplasms. The cutaneous...
4.
Borys S, Reilly S, Magill I, Zemmour D, Brossay L
bioRxiv
. 2023 Sep;
PMID: 37745414
Highlights: Elevated CD8 T cells in the submandibular gland (SMG) of PD-1 deficient mice parallel sicca-like irAEs seen in ICB patients. In addition to their previously described hyporesponsive phenotype, NK...
5.
Larocca C, Shanmugam V, Zemmour D, Antin J, Lane A
Am J Dermatopathol
. 2022 Jun;
44(12):929-932.
PMID: 35642960
No abstract available.
6.
Zemmour D, Goldrath A, Kronenberg M, Kang J, Benoist C
Nat Immunol
. 2022 Apr;
23(5):643-644.
PMID: 35469020
No abstract available.
7.
Corchado-Garcia J, Zemmour D, Hughes T, Bandi H, Cristea-Platon T, Lenehan P, et al.
JAMA Netw Open
. 2021 Nov;
4(11):e2132540.
PMID: 34726743
Importance: Continuous assessment of the effectiveness and safety of the US Food and Drug Administration-authorized SARS-CoV-2 vaccines is critical to amplify transparency, build public trust, and ultimately improve overall health...
8.
Porritt R, Zemmour D, Abe M, Lee Y, Narayanan M, Carvalho T, et al.
Circ Res
. 2021 Sep;
129(9):e183-e200.
PMID: 34517723
[Figure: see text].
9.
Marek-Iannucci S, Ozdemir A, Moreira D, Gomez A, Lane M, Porritt R, et al.
JCI Insight
. 2021 Aug;
6(18).
PMID: 34403365
Kawasaki disease (KD) is the leading cause of acquired heart disease among children. Murine and human data suggest that the NLRP3-IL-1β pathway is the main driver of KD pathophysiology. NLRP3...
10.
Mapping each pre-existing condition's association to short-term and long-term COVID-19 complications
Venkatakrishnan A, Pawlowski C, Zemmour D, Hughes T, Anand A, Berner G, et al.
NPJ Digit Med
. 2021 Jul;
4(1):117.
PMID: 34315980
Understanding the relationships between pre-existing conditions and complications of COVID-19 infection is critical to identifying which patients will develop severe disease. Here, we leverage ~1.1 million clinical notes from 1803...